Nifty
:
20267.90
Sensex
:
67481.19
134.75 (0.67%)
492.75 (0.74%)
Nifty
Sensex
:
:
20267.90
67481.19
134.75 (0.67%)
492.75 (0.74%)

Shilpa Medicare Ltd.

Pharmaceuticals & Drugs - Global

Rating :
40/99

BSE: 530549 | NSE: SHILPAMED

NSE BSE
357.80
01-Dec-2023
  • Open
  • High
  • Low
  • Previous Close
  •  367.40
  •  367.40
  •  356.40
  •  365.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  134506
  •  486.61
  •  397.00
  •  222.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,105.77
  • N/A
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,945.29
  • N/A
  • 1.74

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.01%
  • 12.69%
  • 25.40%
  • FII
  • DII
  • Others
  • 8.6%
  • 0.04%
  • 3.26%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.27
  • 7.44
  • 5.23

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -2.69
  • -10.53
  • -12.46

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 34.17
  • 25.33
  • 57.24

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.32
  • 2.23
  • 2.08

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.12
  • 20.17
  • 22.79

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Dec 22
Dec 21
Var%
Net Sales
312.98
262.91
19.04%
260.18
261.16
-0.38%
263.56
340.59
-22.62%
262.50
272.30
-3.60%
Expenses
252.68
250.71
0.79%
212.26
240.59
-11.78%
225.34
266.87
-15.56%
231.21
227.21
1.76%
EBITDA
60.30
12.20
394.26%
47.92
20.57
132.96%
38.23
73.73
-48.15%
31.29
45.09
-30.61%
EBIDTM
19.27%
4.64%
18.42%
7.88%
14.50%
21.65%
11.92%
16.56%
Other Income
1.81
4.39
-58.77%
1.93
8.10
-76.17%
2.17
5.49
-60.47%
2.74
5.48
-50.00%
Interest
23.24
13.47
72.53%
18.15
9.59
89.26%
17.74
9.35
89.73%
17.86
9.92
80.04%
Depreciation
27.79
23.31
19.22%
26.75
22.42
19.31%
25.69
22.34
15.00%
24.08
20.65
16.61%
PBT
11.08
-20.20
-
4.95
-3.34
-
-3.03
47.41
-
-7.91
20.00
-
Tax
7.60
-3.81
-
2.11
-6.41
-
3.82
16.86
-77.34%
-0.96
9.71
-
PAT
3.48
-16.38
-
2.84
3.08
-7.79%
-6.85
30.55
-
-6.95
10.29
-
PATM
1.11%
-6.23%
1.09%
1.18%
-2.60%
8.97%
-2.65%
3.78%
EPS
0.19
-2.15
-
0.14
0.10
40.00%
-0.93
3.40
-
-0.76
1.10
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
1,099.22
1,050.11
1,145.52
901.13
907.91
733.39
788.83
779.16
716.43
613.80
571.38
Net Sales Growth
-3.32%
-8.33%
27.12%
-0.75%
23.80%
-7.03%
1.24%
8.76%
16.72%
7.42%
 
Cost Of Goods Sold
408.67
415.92
383.22
270.73
277.73
257.03
355.87
371.81
366.19
323.16
313.26
Gross Profit
690.55
634.19
762.30
630.40
630.18
476.36
432.95
407.36
350.25
290.63
258.12
GP Margin
62.82%
60.39%
66.55%
69.96%
69.41%
64.95%
54.89%
52.28%
48.89%
47.35%
45.17%
Total Expenditure
921.49
961.84
948.32
729.43
693.39
579.39
637.60
617.55
556.44
487.38
455.40
Power & Fuel Cost
-
56.79
52.43
40.25
38.76
33.57
28.86
26.30
21.90
19.29
17.37
% Of Sales
-
5.41%
4.58%
4.47%
4.27%
4.58%
3.66%
3.38%
3.06%
3.14%
3.04%
Employee Cost
-
287.33
264.49
235.31
196.59
176.40
149.35
127.87
90.09
82.30
67.83
% Of Sales
-
27.36%
23.09%
26.11%
21.65%
24.05%
18.93%
16.41%
12.57%
13.41%
11.87%
Manufacturing Exp.
-
114.40
124.11
91.29
79.19
61.23
59.96
52.55
45.35
36.55
27.44
% Of Sales
-
10.89%
10.83%
10.13%
8.72%
8.35%
7.60%
6.74%
6.33%
5.95%
4.80%
General & Admin Exp.
-
46.83
71.58
47.71
70.26
27.20
22.50
16.95
14.11
10.64
9.53
% Of Sales
-
4.46%
6.25%
5.29%
7.74%
3.71%
2.85%
2.18%
1.97%
1.73%
1.67%
Selling & Distn. Exp.
-
6.62
18.02
18.63
10.40
6.72
6.37
4.75
7.27
5.99
7.29
% Of Sales
-
0.63%
1.57%
2.07%
1.15%
0.92%
0.81%
0.61%
1.01%
0.98%
1.28%
Miscellaneous Exp.
-
33.95
34.49
25.51
20.47
17.23
14.68
17.32
11.54
9.45
7.29
% Of Sales
-
3.23%
3.01%
2.83%
2.25%
2.35%
1.86%
2.22%
1.61%
1.54%
2.22%
EBITDA
177.74
88.27
197.20
171.70
214.52
154.00
151.23
161.61
159.99
126.42
115.98
EBITDA Margin
16.17%
8.41%
17.21%
19.05%
23.63%
21.00%
19.17%
20.74%
22.33%
20.60%
20.30%
Other Income
8.65
31.41
20.90
40.09
22.22
15.56
32.62
29.34
11.36
6.93
9.12
Interest
76.99
58.65
41.17
21.87
4.56
3.68
2.66
3.13
3.93
4.05
3.52
Depreciation
104.31
95.50
79.80
53.98
43.78
42.06
37.22
30.64
23.14
21.41
23.22
PBT
5.09
-34.47
97.13
135.95
188.40
123.82
143.96
157.17
144.28
107.89
98.35
Tax
12.57
-7.36
41.68
48.85
33.49
26.18
33.91
42.04
35.62
35.22
20.30
Tax Rate
246.95%
21.35%
39.35%
24.82%
17.78%
18.22%
23.56%
27.54%
25.11%
32.66%
21.27%
PAT
-7.48
-32.48
60.66
147.78
156.50
120.28
112.43
113.71
109.84
73.69
75.67
PAT before Minority Interest
-7.43
-30.92
60.58
146.20
154.91
117.52
110.05
110.59
106.24
72.62
75.15
Minority Interest
0.05
-1.56
0.08
1.58
1.59
2.76
2.38
3.12
3.60
1.07
0.52
PAT Margin
-0.68%
-3.09%
5.30%
16.40%
17.24%
16.40%
14.25%
14.59%
15.33%
12.01%
13.24%
PAT Growth
-127.16%
-
-58.95%
-5.57%
30.11%
6.98%
-1.13%
3.52%
49.06%
-2.62%
 
EPS
-0.86
-3.74
6.99
17.03
18.03
13.86
12.95
13.10
12.65
8.49
8.72

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
1,783.28
1,822.19
1,478.67
1,329.36
1,197.58
1,085.03
986.90
639.26
546.94
396.45
Share Capital
8.68
8.68
8.15
8.15
8.15
8.15
8.01
7.71
7.71
7.36
Total Reserves
1,774.60
1,813.51
1,470.51
1,321.21
1,189.43
1,076.88
978.88
631.55
539.23
389.09
Non-Current Liabilities
345.11
452.82
561.37
256.94
166.62
153.48
251.26
67.23
154.15
104.53
Secured Loans
242.92
353.49
473.87
164.48
80.39
67.09
141.20
0.03
71.03
37.43
Unsecured Loans
45.90
0.11
0.35
0.53
0.70
1.03
1.30
0.00
31.30
30.05
Long Term Provisions
17.65
19.08
15.48
26.17
21.77
20.32
16.89
13.96
11.75
9.93
Current Liabilities
782.91
611.54
543.29
410.82
253.44
265.84
236.90
222.07
189.06
166.84
Trade Payables
144.41
146.04
67.25
92.55
80.72
103.74
111.86
106.48
75.50
92.98
Other Current Liabilities
273.63
240.13
219.33
142.10
81.62
59.59
28.03
36.49
49.32
38.23
Short Term Borrowings
344.17
202.90
243.40
165.27
86.58
98.12
92.41
74.10
58.47
30.27
Short Term Provisions
20.70
22.46
13.31
10.89
4.52
4.39
4.60
5.00
5.77
5.37
Total Liabilities
2,902.38
2,875.50
2,572.16
1,989.21
1,610.02
1,499.13
1,472.22
930.89
904.54
677.83
Net Block
1,368.33
1,341.84
1,110.53
650.44
558.01
534.20
491.93
393.41
316.06
294.42
Gross Block
1,846.68
1,727.09
1,421.10
986.42
853.16
793.24
704.89
582.20
476.34
448.38
Accumulated Depreciation
478.35
385.25
310.57
335.98
295.15
259.04
212.96
188.79
160.28
153.96
Non Current Assets
2,134.37
1,988.30
1,729.60
1,365.35
1,064.96
827.16
742.33
576.68
576.77
443.89
Capital Work in Progress
655.33
506.18
541.29
666.25
429.12
209.85
140.51
91.90
221.62
111.03
Non Current Investment
42.66
34.23
21.22
10.45
2.25
20.79
27.99
34.15
0.19
0.21
Long Term Loans & Adv.
56.58
93.90
43.10
32.42
48.75
37.47
77.09
51.86
38.74
38.18
Other Non Current Assets
11.47
12.15
13.46
5.78
26.84
24.86
4.80
5.36
0.16
0.06
Current Assets
768.01
887.19
818.99
623.85
545.06
671.97
729.88
354.21
327.61
233.74
Current Investments
0.00
0.00
0.00
0.00
0.00
119.54
224.62
59.63
65.35
10.14
Inventories
319.82
355.24
316.84
226.43
187.67
188.71
190.00
134.23
130.78
123.25
Sundry Debtors
324.35
386.33
217.50
246.79
203.73
220.27
170.93
125.43
81.37
67.96
Cash & Bank
21.56
34.11
123.11
44.56
94.54
73.83
100.39
11.03
18.42
9.19
Other Current Assets
102.28
9.36
98.73
76.81
59.12
69.62
43.95
23.90
31.69
23.20
Short Term Loans & Adv.
87.94
102.16
62.81
29.25
14.08
43.54
21.95
8.90
4.91
3.23
Net Current Assets
-14.90
275.66
275.69
213.04
291.62
406.13
492.98
132.14
138.55
66.90
Total Assets
2,902.38
2,875.49
2,548.59
1,989.20
1,610.02
1,499.13
1,472.21
930.89
904.54
677.83

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
226.17
105.13
46.93
124.38
146.78
44.92
37.48
128.70
68.81
70.04
PBT
-38.28
102.26
196.79
188.40
143.70
136.77
146.49
140.36
107.84
95.45
Adjustment
148.15
109.34
4.03
41.32
20.44
18.83
17.19
20.61
26.46
19.62
Changes in Working Capital
148.68
-71.99
-106.29
-63.15
18.71
-69.66
-92.61
-2.70
-40.11
-23.44
Cash after chg. in Working capital
258.55
139.62
94.53
166.57
182.85
85.94
71.08
158.27
94.19
91.62
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-32.37
-34.48
-47.60
-42.20
-36.07
-41.02
-33.60
-29.56
-25.38
-21.58
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-278.48
-285.50
-404.28
-289.52
-196.16
-8.76
-262.23
-109.20
-195.18
-48.93
Net Fixed Assets
-22.18
384.16
-272.02
-4.28
-256.96
-136.75
-172.23
-92.14
-78.46
-61.02
Net Investments
-6.42
-18.18
-125.84
-4.44
141.85
95.51
-172.72
-14.09
-64.38
12.08
Others
-249.88
-651.48
-6.42
-280.80
-81.05
32.48
82.72
-2.97
-52.34
0.01
Cash from Financing Activity
45.80
82.86
436.37
175.50
10.06
-60.91
312.70
-19.65
135.05
-28.34
Net Cash Inflow / Outflow
-6.51
-97.51
79.03
10.36
-39.32
-24.75
87.95
-0.15
8.68
-7.23
Opening Cash & Equivalents
25.34
122.85
44.31
34.13
73.83
99.97
7.05
3.61
9.19
16.87
Closing Cash & Equivalent
18.82
25.34
123.34
44.31
34.36
73.83
99.97
6.43
18.42
9.19

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
205.44
209.93
181.37
163.06
146.89
133.09
123.17
82.91
70.92
107.72
ROA
-1.07%
2.20%
6.33%
8.61%
7.56%
7.41%
9.20%
11.58%
9.18%
12.23%
ROE
-1.71%
3.67%
10.41%
12.26%
10.30%
10.62%
13.60%
17.92%
15.40%
20.98%
ROCE
0.80%
5.94%
10.73%
12.41%
11.05%
11.71%
15.91%
19.90%
17.90%
20.48%
Fixed Asset Turnover
0.59
0.73
0.75
0.99
0.89
1.06
1.22
1.36
1.34
1.54
Receivable days
123.51
98.75
94.03
90.56
105.51
90.20
69.00
52.26
43.99
34.62
Inventory Days
117.32
109.68
110.03
83.24
93.66
87.32
75.49
66.97
74.84
62.33
Payable days
127.45
106.00
107.72
47.69
58.00
61.51
60.89
60.10
62.86
57.06
Cash Conversion Cycle
113.38
102.43
96.33
126.11
141.17
116.00
83.61
59.13
55.97
39.90
Total Debt/Equity
0.45
0.37
0.57
0.29
0.16
0.18
0.24
0.14
0.34
0.30
Interest Cover
0.35
3.48
9.92
42.34
40.09
55.10
49.69
37.07
27.63
28.09

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014

News Update:


  • Shilpa Medicare to sell 4% stake in Sravathi
    17th Nov 2023, 09:59 AM

    The company has entered into Share Subscription and Shareholder’s agreement with Ash Ingredients

    Read More
  • Shilpa Medicare - Quarterly Results
    10th Nov 2023, 14:57 PM

    Read More
  • Shilpa Medicare acquires Pilnova Pharma in United States
    3rd Nov 2023, 10:30 AM

    The object of acquisition is to establish front end presence in the US Market with an objective to capture the full potential of its niche portfolios

    Read More
  • TGA Australia concludes GMP inspection at Shilpa Medicare’s Telangana facility
    17th Oct 2023, 14:22 PM

    The successful closure of this inspection will allow the company to register and market its products in Australia and other rest of world markets which recognize Australian GMP

    Read More
  • Shilpa Medicare launches Naturally Derived Option for Treatment of Oral Mucositis in India
    12th Oct 2023, 09:50 AM

    ORAAL, a substantial advancement in Oral Mucositis management, has been accepted and approved by the Indian Dental Association

    Read More
  • Shilpa Medicare gets marketing authorization for Betahistine Dihydrochloride Orodispersible Films
    4th Sep 2023, 11:52 AM

    This approval has come from the Company’s finished dosage form manufacturing facility, Shilpa Medicare, Unit VI, located at Dabaspet, Bengaluru, Karnataka

    Read More
  • Shilpa Medicare’s finished dosage form manufacturing facility clears GMP inspection by ANVISA, Brazil
    25th Aug 2023, 14:42 PM

    The inspection has concluded successfully on August 24, 2023 without any observations

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.